The Latest Melatonin Industry Statistics Explained
In 2020, the global Melatonin market size was USD 1234.8 million
In 2020, the global Melatonin market size was reported to be USD 1234.8 million. This statistic represents the total value of sales or revenue generated by the global market for Melatonin products in that year. The market size figure indicates the significant economic activity and consumer demand for Melatonin-based products, which are often used as dietary supplements to regulate sleep patterns and treat insomnia. The reported market size gives insight into the scale of the Melatonin industry and its importance within the larger global healthcare and wellness market.
It is projected that by 2027, the market will reach USD 1838.3 million
The statistic suggests a future projection for the market size, stating that by the year 2027, it is expected to reach a value of USD 1838.3 million. This figure serves as an estimation of the total worth of the market at that point in time, indicating potential growth or changes in economic conditions that may impact the industry. Such projections are based on various factors such as historical data, market trends, and forecasting models, providing insights for businesses and investors to make informed decisions and strategies for the future.
The Compound Annual Growth Rate (CAGR) from 2021 to 2027 is forecast to be 5.3%
The Compound Annual Growth Rate (CAGR) of 5.3% from 2021 to 2027 implies that the underlying variable or metric, such as revenue, profits, or market size, is expected to grow at a consistent annual rate of 5.3% over the specified period. This growth rate takes into account compounding effects, meaning the rate applies to the growth of the initial value over multiple years. Therefore, if the projection holds true, the value of the metric being measured is estimated to increase by an average of 5.3% each year from 2021 to 2027, resulting in a cumulative growth of around 41.16% (1.053^6) over the entire period.
The Melatonin market in North America was USD 458.5 million in 2020
The statistic indicates that the total market value of Melatonin products in North America amounted to USD 458.5 million in the year 2020. This figure represents the combined revenue generated from the sales of Melatonin supplements, medications, and other related products throughout North America during that year. The size of the Melatonin market suggests a significant demand for these products, likely driven by factors such as an increasing awareness of the potential benefits of Melatonin for sleep disorders and other health issues. This information is valuable for businesses operating in the Melatonin industry, as it provides insights into the market’s overall size and potential opportunities for growth and expansion in the region.
Europe’s melatonin market was worth USD 349.0 million in 2020
The statistic “Europe’s melatonin market was worth USD 349.0 million in 2020” represents the total value of melatonin products sold in the European market during that year. Melatonin is a hormone naturally produced in the body that is also available as a dietary supplement commonly used for its potential sleep-inducing properties. The market value of USD 349.0 million indicates the monetary worth of all melatonin products sold, including capsules, tablets, and other formulations in Europe in 2020. This statistic is significant for businesses, policymakers, and researchers as it provides insight into the demand and economic impact of melatonin in the European region during that particular year.
The sales of melatonin in the Asia Pacific region grew by 6.9% for the year ending 2020
The statistic indicates that the sales of melatonin supplements in the Asia Pacific region experienced a growth of 6.9% from the previous year to the end of 2020. This growth rate suggests an increasing demand for melatonin products in the region, possibly driven by factors such as rising awareness of and interest in sleep health, lifestyle changes, and a growing aging population. The increase in sales could also be indicative of the effectiveness of marketing strategies, product innovation, and the overall acceptance of melatonin as a safe and natural sleep aid. The 6.9% growth rate provides insights into the market trends and consumer behavior in relation to the usage of melatonin supplements in the Asia Pacific region.
Nearly 80% of melatonin sales are from the dietary supplements market
This statistic indicates that the majority (specifically, nearly 80%) of melatonin sales come from the dietary supplements market. Melatonin is a natural hormone that helps regulate sleep-wake cycles, and many people use it as a supplement to improve sleep quality or manage sleep disorders. The fact that such a large portion of melatonin sales is attributed to the dietary supplements market highlights the widespread popularity and demand for melatonin as a sleep aid or supplement. This statistic suggests that the dietary supplements industry plays a significant role in the distribution and consumption of melatonin products, reflecting a growing trend of individuals seeking alternative approaches to managing their sleep patterns.
The global melatonin market is dominated by five major players, accounting for 45% of the total market
The statistic stating that the global melatonin market is dominated by five major players, accounting for 45% of the total market, suggests that a significant portion of the industry is controlled by a small number of companies. This indicates a high level of market concentration, with these five companies holding substantial market power and influence. Their dominance implies that they likely have strong brand recognition, economies of scale, and perhaps significant barriers to entry for potential competitors. As major players, they most likely also have the ability to impact market trends, set prices, and shape the overall direction of the melatonin market.
Melatonin purchases peaked during the COVID-19 pandemic in 2020, jumping by 42.6%
The statistic indicates that there was a substantial increase in the purchases of melatonin during the COVID-19 pandemic in 2020. Specifically, the purchases surged by 42.6% compared to previous periods. This sharp rise in melatonin purchases may suggest a higher demand for sleep aids and stress-relief products during the pandemic, as individuals experienced disrupted sleep patterns, heightened anxiety, and difficulties in adjusting to the new realities of the global health crisis. The significant increase in melatonin sales can be interpreted as a reflection of the population’s increased focus on managing their mental well-being and seeking solutions to cope with the challenges brought about by the pandemic.
The medical segment in the melatonin market is expected to grow at a CAGR of over 4% by 2027
This statistic indicates that the medical segment within the melatonin market is projected to experience a Compound Annual Growth Rate (CAGR) of more than 4% by the year 2027. This implies that the demand for melatonin products within the medical sector, whether it be for sleep disorders, mental health conditions, or other medical purposes, is anticipated to steadily increase at a rate exceeding 4% annually until 2027. This growth rate suggests a positive trend in the use of melatonin within the medical field, potentially driven by factors such as increasing awareness of its benefits, expanding research supporting its efficacy, and a growing need for alternative treatment options in healthcare.
The average price of melatonin has been falling at about 2% per annum over the past five years
This statistic indicates that the average price of melatonin, a supplement commonly used for improving sleep, has been decreasing steadily at a rate of approximately 2% per year over the past five years. This suggests that consumers have been able to purchase melatonin at progressively lower prices, likely due to factors such as increased competition in the market, improved production efficiency, or changes in consumer demand. A 2% annual decrease may not seem substantial in the short term, but over five years, it can potentially lead to notable cost savings for individuals relying on melatonin as a sleep aid.
80% of melatonin users in the United States are women
The statistic ‘80% of melatonin users in the United States are women’ indicates that a significant majority of individuals who use melatonin as a sleep aid in the United States are female. This statistic suggests that there may be gender differences in the prevalence or reasons for using melatonin, potentially reflecting varying sleep patterns, preferences, or health concerns between men and women. Understanding this demographic breakdown can be important for healthcare providers, researchers, and marketers in tailoring their strategies and products to better meet the needs of the predominant user group and potentially explore any underlying reasons for this gender disparity in melatonin usage.
By 2026, the melatonin market in APAC is expected to reach USD 593 million
The statistic that “By 2026, the melatonin market in APAC is expected to reach USD 593 million” indicates the projected size of the melatonin market in the Asia-Pacific region by the year 2026. This figure represents the total value of melatonin products that are anticipated to be sold and consumed within the region during that year, with a predicted value of USD 593 million. This statistic suggests a growing demand for melatonin products, likely driven by factors such as increasing awareness of melatonin’s potential benefits for improving sleep and managing certain health conditions. The projected market size also indicates opportunities for businesses operating in the melatonin industry to capitalize on this expected growth in the APAC region.
In 2020, 15% of adults in the United States reported using sleep aids like melatonin
The statistic “In 2020, 15% of adults in the United States reported using sleep aids like melatonin” indicates that a significant proportion of adults in the United States relied on sleep aids to help with their sleep in the year 2020. This statistic suggests that sleep issues were prevalent among the adult population during that time, leading many individuals to seek assistance in the form of sleep aids. The use of melatonin specifically, a commonly used over-the-counter sleep aid known for its role in regulating sleep-wake cycles, highlights the importance of addressing sleep disturbances and the need for effective solutions to promote better sleep quality among adults in the United States.
The melatonin market in Latin America was valued at USD 57.6 million in 2020
The statistic “The melatonin market in Latin America was valued at USD 57.6 million in 2020” indicates the total worth of the melatonin market in terms of monetary value within the Latin American region during the specified year. This figure provides insight into the size and economic significance of the melatonin market in Latin America, highlighting the demand for melatonin products and the growth potential of the industry. The value of USD 57.6 million suggests that there is a notable market for melatonin products in the region, with consumers showing interest and willingness to spend on such products for various purposes like improving sleep quality, managing jet lag, or addressing other health-related concerns.
The Melatonin market in the Middle East & Africa is expected to surpass USD 100 million by 2027
The statistic that the Melatonin market in the Middle East & Africa is projected to exceed USD 100 million by 2027 indicates a strong anticipated growth trend in the region for this particular product. Melatonin is a hormone that can be used as a dietary supplement to aid in sleep regulation and manage issues related to sleep disorders. The forecasted figure suggests a significant increase in demand for melatonin products within the Middle East & Africa market, likely driven by factors such as a growing awareness about the importance of sleep quality, changing lifestyles, and a rise in the prevalence of sleep-related conditions. Businesses operating in the melatonin market may see this projection as an opportunity for expansion and strategic investment in the region to capitalize on the expected market growth.
The sale of melatonin for insomnia is forecasted to grow by 6.1% over the forecasted period (2021-2027)
The statistic indicates that the sale of melatonin, a supplement commonly used for treating insomnia, is projected to increase by 6.1% over the forecasted period spanning from 2021 to 2027. This growth forecast suggests a rising demand for melatonin as a sleep aid, likely driven by factors such as increasing awareness of the supplement’s benefits, a higher prevalence of sleep disorders, and a trend towards natural and alternative remedies for improving sleep quality. The statistic highlights a potential opportunity for businesses operating in the sleep aid industry and underscores the importance of addressing the growing need for insomnia management solutions in the market.
E-commerce channels is projected to be the fastest-growing distribution channel for melatonin, at a CAGR of 8.2% from 2021 to 2028
This statistic indicates that the sales and distribution of melatonin products through e-commerce channels are expected to experience rapid growth, with a projected Compound Annual Growth Rate (CAGR) of 8.2% between the years 2021 and 2028. This growth rate suggests that consumers are increasingly turning to online platforms to purchase melatonin supplements, likely due to the convenience, wide variety of products available, and ease of comparison shopping. The trend highlights the shifting landscape of retail towards digital platforms and signifies a significant opportunity for businesses in the melatonin industry to capitalize on the expanding e-commerce market for their products.
Western Europe was the largest geographic segment in the global melatonin market accounting for 43% of the market in 2020
This statistic indicates that Western Europe held the largest share of the global melatonin market in 2020, accounting for 43% of the total market. This suggests that the region had a significant impact on the overall sales and consumption of melatonin products worldwide. Factors such as high awareness of the benefits of melatonin, favorable regulations, and strong market demand could have contributed to Western Europe’s dominant position in the market. Companies operating in the melatonin industry may have strategically targeted this region due to its market potential and established consumer base. Overall, this statistic highlights the importance of Western Europe as a key player in the global melatonin market and emphasizes the region’s influence on the industry as a whole.
References
0. – https://www.www.cdc.gov
1. – https://www.www.marketsandmarkets.com
2. – https://www.www.nielsen.com
3. – https://www.www.globenewswire.com
4. – https://www.www.marketdataforecast.com
5. – https://www.www.reportsnreports.com
6. – https://www.www.grandviewresearch.com
7. – https://www.www.researchandmarkets.com
8. – https://www.www.prnewswire.com
